K Snow1, A C Hesseling2, P Naidoo2, S M Graham3, J Denholm4, K du Preez2. 1. Centre for International Child Health, University of Melbourne, Department of Paediatrics and Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. 2. Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. 3. Centre for International Child Health, University of Melbourne, Department of Paediatrics and Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, International Union Against Tuberculosis and Lung Disease, Paris, France. 4. Victorian Tuberculosis Program, Melbourne Health, Melbourne, Victoria, Department of Microbiology and Immunology, University of Melbourne, Melbourne, Victoria, Australia.
Abstract
SETTING: Western Cape Province, South Africa. OBJECTIVES: To characterise tuberculosis (TB) epidemiology, disease presentation and treatment outcomes among adolescents (age 10-19 years) and young adults (age 20-24 years) in the Western Cape. DESIGN: A retrospective, cross-sectional review of routine patient-level data from the Electronic TB Register (ETR.Net) for 2013. Site of TB disease, human immunodeficiency virus (HIV) status and TB treatment outcomes were analysed by 5-year age groups (<5, 5-9, 10-14, 15-19, 20-24 and 25 years of age). TB notification rates were calculated using census data. RESULTS: Adolescents and young adults comprised 18.0% of all new TB notifications in 2013. The notification rate was 141 TB cases/100 000 person-years (py) among 10-14 year olds, 418/100 000 py among 15-19 year olds and 627/100 000 py among 20-24 year olds. HIV prevalence among TB patients was 10.9% in 10-14 year olds, 8.8% in 15-19 year olds and 27.2% in 20-24 year olds. Older adolescents (age 15-19 years) and young adults (age 20-24 years) with HIV co-infection had poor treatment outcomes: 15.6% discontinued treatment prematurely and 4.0% died. CONCLUSIONS: Young people in the Western Cape suffer a substantial burden of TB, and those with TB-HIV co-infection are at high risk of treatment discontinuation.
SETTING: Western Cape Province, South Africa. OBJECTIVES: To characterise tuberculosis (TB) epidemiology, disease presentation and treatment outcomes among adolescents (age 10-19 years) and young adults (age 20-24 years) in the Western Cape. DESIGN: A retrospective, cross-sectional review of routine patient-level data from the Electronic TB Register (ETR.Net) for 2013. Site of TB disease, human immunodeficiency virus (HIV) status and TB treatment outcomes were analysed by 5-year age groups (<5, 5-9, 10-14, 15-19, 20-24 and 25 years of age). TB notification rates were calculated using census data. RESULTS: Adolescents and young adults comprised 18.0% of all new TB notifications in 2013. The notification rate was 141 TB cases/100 000 person-years (py) among 10-14 year olds, 418/100 000 py among 15-19 year olds and 627/100 000 py among 20-24 year olds. HIV prevalence among TB patients was 10.9% in 10-14 year olds, 8.8% in 15-19 year olds and 27.2% in 20-24 year olds. Older adolescents (age 15-19 years) and young adults (age 20-24 years) with HIV co-infection had poor treatment outcomes: 15.6% discontinued treatment prematurely and 4.0% died. CONCLUSIONS: Young people in the Western Cape suffer a substantial burden of TB, and those with TB-HIV co-infection are at high risk of treatment discontinuation.
Authors: Leslie A Enane; Elizabeth D Lowenthal; Tonya Arscott-Mills; Jessica Eby; Cynthia Caiphus; Botshelo Kgwaadira; Susan E Coffin; Andrew P Steenhoff Journal: Pediatr Infect Dis J Date: 2019-10 Impact factor: 2.129
Authors: L A Enane; J Eby; T Arscott-Mills; S Argabright; C Caiphus; B Kgwaadira; A P Steenhoff; E D Lowenthal Journal: Int J Tuberc Lung Dis Date: 2020-02-01 Impact factor: 2.373
Authors: Erick W Bunyasi; Keren Middelkoop; Anastasia Koch; Zeenat Hoosen; Humphrey Mulenga; Angelique K K Luabeya; Justin Shenje; Simon C Mendelsohn; Michele Tameris; Thomas J Scriba; Digby F Warner; Robin Wood; Jason R Andrews; Mark Hatherill Journal: Am J Respir Crit Care Med Date: 2022-02-01 Impact factor: 21.405
Authors: T N Mann; H S Schaaf; R N Dunn; S Dix-Peek; K du Preez; R P Lamberts; J du Toit; J H Davis Journal: Epidemiol Infect Date: 2018-09-28 Impact factor: 4.434
Authors: Kathryn J Snow; Lisa J Nelson; Charalambos Sismanidis; Susan M Sawyer; Stephen M Graham Journal: Epidemiol Infect Date: 2018-04-15 Impact factor: 4.434
Authors: Muhammad Osman; Karen du Preez; James A Seddon; Mareli M Claassens; Rory Dunbar; Sicelo S Dlamini; Alex Welte; Pren Naidoo; Anneke C Hesseling Journal: Pediatrics Date: 2021-03-10 Impact factor: 7.124
Authors: K M Laycock; J Eby; T Arscott-Mills; S Argabright; C Caiphus; B Kgwaadira; E D Lowenthal; A P Steenhoff; L A Enane Journal: Int J Tuberc Lung Dis Date: 2021-07-01 Impact factor: 3.427
Authors: Marcia C B de Oliveira; Clemax C Sant'Anna; Ronir Raggio Luiz; Afrânio L Kritski Journal: Am J Trop Med Hyg Date: 2020-09-17 Impact factor: 3.707
Authors: Kathryn J Snow; Andrea T Cruz; James A Seddon; Rashida A Ferrand; Silvia S Chiang; Jennifer A Hughes; Beate Kampmann; Steve M Graham; Peter J Dodd; Rein M Houben; Justin T Denholm; Susan M Sawyer; Katharina Kranzer Journal: Lancet Child Adolesc Health Date: 2019-11-18